Clinical Trial Update: A Study of INCMGA00012 in Squamous Carcinoma of the Anal Canal Following Platinum-Based Chemotherapy (POD1UM-202) [Phase 2]

View source ↗

Summary

Phase 2 trial update reporting results for INCMGA00012 in squamous cell carcinoma of the anal canal after platinum-based chemotherapy; study completed with resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Squamous Cell Carcinoma of the Anal Canal

Drugs mentioned

• INCMGA00012

Snippet

Sponsor: Incyte Corporation | Conditions: Squamous Cell Carcinoma of Anal Canal | Phase 2 | Status: COMPLETED | Results posted: 2021-08-23